Viavi price target raised by $2 at Rosenblatt, here’s why

Rosenblatt raised the firm’s price target on Viavi to $12 from $10 and keeps a Buy rating on the shares. After “a tough year of negative estimate revisions for the sector,” the firm is becoming increasing bullish the bottom may be in and calls Viavi an “attractive stock to buy early” since it almost always sees downturns and recoveries before the network equipment manufacturers with longer lead times and more inventory concerns, the analyst tells investors.